Early discharge after intensive AML, MDS chemo can reduce costs, antibiotics use
the ONA take:
Early discharge following intensive acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) can reduce costs and use of intravenous antibiotics, according to a new study published online ahead of print in JAMA Oncology.
Because adults with AML or MDS typically remain hospitalized after induction or salvage chemotherapy, health care costs are driven up by the prolonged inpatient stay. Researchers sought to evaluate whether early discharge and outpatient management would be safe and reduce costs for these patients.
For the study, researchers from the University of Washington and Fred Hutchinson Cancer Research Center in Seattle enrolled 146 patients with AML or MDS. Of those, 107 were discharged early and 29 served as inpatient controls. The early discharge patients were released from the hospital at the completion of chemotherapy and were provided with supportive care in the outpatient setting.
Results showed no significant difference in intensive care unit (ICU) days or transfusions per study day between the two treatment arms. Early discharge patients had more positive blood cultures than the inpatient controls but required fewer intravenous antibiotics. Costs were also lower for the early discharge group than for inpatients but had increased costs per inpatient day when readmitted for complications.
Outpatient Management Following Intensive AML or MDS Chemotherapy
Sign Up for Free e-newsletters
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Oncology Extended Care Clinic Reduced Urgent Cancer-Related ED Visits
- Cervical Cancer Outcomes Comparable With Adjuvant Chemotherapy, Chemoradiotherapy
- Hair Dyes and Cancer Risk (Fact Sheet)
- Taste Changes After Hematopoietic Stem Cell Transplant Affect QOL in Blood Cancers
- Hope, Optimism Reduce Psychological Distress in Advanced Cancer
- Risk for Long-Term Cardiovascular Disease Increased for Endometrial Cancer Survivors
- Mitomycin Extravasation Protocol
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes
- Internal Benchmarking Improves Nurse Workflow, Staffing in Radiation Oncology
- Flu, Pneumonia Vaccination Rates in Cancer Patients Improved With Nurse-Driven Protocol
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|